Literature DB >> 23257209

IFPA Meeting 2012 Workshop Report III: trophoblast deportation, gestational trophoblastic disease, placental insufficiency and fetal growth restriction, trophoblast over-invasion and accreta-related pathologies, placental thrombosis and fibrinolysis.

A Al-Khan1, J N Bulmer, F Chantraine, C P Chen, Q Chen, S Collins, T Cotechini, J S Fitzgerald, M He, O Holland, T H Hung, N P Illsley, K Ino, T Iwaki, N Kanayama, E Kaneki, H Katabuchi, Y Kobayashi, A Kondo, H Masuzaki, M Matjila, K Miura, A Mori, P Murthi, K Nagahashi, G Nie, T Ohba, R Sood, M Sugimura, T Takizawa, H Usui, P Velicky, G E Lash.   

Abstract

Workshops are an important part of the IFPA annual meeting as they allow for discussion of specialized topics. At IFPA meeting 2012 there were twelve themed workshops, five of which are summarized in this report. These workshops related to various aspects of placental biology but collectively covered areas of clinical research and pregnancy disorders: 1) trophoblast deportation; 2) gestational trophoblastic disease; 3) placental insufficiency and fetal growth restriction; 4) trophoblast overinvasion and accreta-related pathologies; 5) placental thrombosis and fibrinolysis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23257209     DOI: 10.1016/j.placenta.2012.11.018

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  2 in total

1.  Bidirectional regulation between 1st trimester HTR8/SVneo trophoblast cells and in vitro differentiated Th17/Treg cells suggest a fetal-maternal regulatory loop in human pregnancy.

Authors:  Songcun Wang; Jinfeng Qian; Fengrun Sun; Mengdie Li; Jiangfeng Ye; Mingqing Li; Meirong Du; Dajin Li
Journal:  Am J Reprod Immunol       Date:  2019-04-11       Impact factor: 3.886

2.  IL‑33 restricts invasion and adhesion of trophoblast cell line JEG3 by downregulation of integrin α4β1 and CD62L.

Authors:  Xiao-Hui Wang; Wei Liu; Deng-Xuan Fan; Wen-Ting Hu; Ming-Qing Li; Xiao-Yong Zhu; Li-Ping Jin
Journal:  Mol Med Rep       Date:  2017-07-26       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.